SG Americas Securities’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$266K Buy
8,048
+1,317
+20% +$43.5K ﹤0.01% 1875
2025
Q1
$271K Buy
+6,731
New +$271K ﹤0.01% 2047
2024
Q4
Sell
-22,203
Closed -$1.17M 2780
2024
Q3
$1.17M Sell
22,203
-115,939
-84% -$6.12M ﹤0.01% 837
2024
Q2
$7.49M Buy
138,142
+129,057
+1,421% +$6.99M 0.04% 367
2024
Q1
$637K Sell
9,085
-14,073
-61% -$987K ﹤0.01% 1181
2023
Q4
$1.93M Sell
23,158
-1,221
-5% -$102K 0.02% 618
2023
Q3
$718K Buy
+24,379
New +$718K 0.01% 1400
2023
Q2
Sell
-46,654
Closed -$1.64M 2140
2023
Q1
$1.64M Buy
46,654
+43,156
+1,234% +$1.52M 0.02% 714
2022
Q4
$160K Sell
3,498
-2,093
-37% -$95.7K ﹤0.01% 2154
2022
Q3
$271K Sell
5,591
-3,631
-39% -$176K ﹤0.01% 1847
2022
Q2
$362K Sell
9,222
-40,422
-81% -$1.59M ﹤0.01% 2030
2022
Q1
$1.83M Sell
49,644
-14,157
-22% -$521K 0.01% 856
2021
Q4
$2.91M Sell
63,801
-3,128
-5% -$143K 0.02% 727
2021
Q3
$2.39M Buy
66,929
+50,152
+299% +$1.79M 0.01% 995
2021
Q2
$332K Sell
16,777
-3,574
-18% -$70.7K ﹤0.01% 1916
2021
Q1
$473K Sell
20,351
-10,706
-34% -$249K ﹤0.01% 1871
2020
Q4
$645K Sell
31,057
-2,059
-6% -$42.8K ﹤0.01% 1575
2020
Q3
$717K Buy
33,116
+16,989
+105% +$368K ﹤0.01% 1164
2020
Q2
$380K Sell
16,127
-31,637
-66% -$745K ﹤0.01% 2001
2020
Q1
$563K Buy
+47,764
New +$563K 0.01% 1433
2019
Q4
Sell
-14,708
Closed -$167K 2705
2019
Q3
$167K Buy
+14,708
New +$167K ﹤0.01% 2095
2019
Q2
Sell
-18,642
Closed -$151K 2611
2019
Q1
$151K Buy
+18,642
New +$151K ﹤0.01% 2415
2017
Q4
Sell
-9,360
Closed -$136K 2619
2017
Q3
$136K Sell
9,360
-4,946
-35% -$71.9K ﹤0.01% 2560
2017
Q2
$173K Buy
14,306
+6,052
+73% +$73.2K ﹤0.01% 2224
2017
Q1
$106K Sell
8,254
-7,297
-47% -$93.7K ﹤0.01% 2620
2016
Q4
$189K Buy
+15,551
New +$189K ﹤0.01% 2119